Jpmorgan Chase & CO Anixa Biosciences Inc Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Dec 26, 2024	BUY	$2.85 - $4.19 $19,542 - $28,730	6,857 New	6,857 $26,000
Q4 2023 Feb 12, 2024	SELL	$2.85 - $4.19 $58,231 - $85,610	-20,432 Reduced 74.87%	6,857 $26,000
Q2 2023 Aug 11, 2023	BUY	$3.0 - $5.97 $64,917 - $129,184	21,639 Added 382.99%	27,289 $87,000
Q1 2023 May 11, 2023	BUY	$3.86 - $5.0 $19,300 - $25,000	5,000 Added 769.23%	5,650 $24,000
Q3 2021 Nov 12, 2021	BUY	$3.57 - $5.6 $2,320 - $3,639	650 New	650 $3,000

5.53M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $69M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.